Analyst Information for Alnylam Pharmaceuticals Inc.

$ 81.67   0.82 (+1.01%) Volume: 793.17k 4:00 PM EDT Oct 16, 2019
After Hours:  $ 81.67 0.00 (0.00%) Volume: 41.38k 4:08 PM EDT Oct 16, 2019
Consensus Rating Average
Consensus Rating for ALNY is STRONG BUY
Since many brokers have different rating systems, we maintain a standard system with an assigned numeric value from 1 to 5. Ratings are a translation of brokers' recommendations to the recommendation scale, which ranges from a rating of 1 (a strong buy) to a rating of 5 (a strong sell).
Rating Scale
Strong Buy 1.0 - 1.5
Moderate Buy 1.6 - 2.5
Hold 2.6 - 3.5
Moderate Sell 3.6 - 4.5
Strong Sell 4.6 - 5.0
Consensus Rating Details
Current Average Recommendation 1.41
Previous Average Recommendation 1.41
Change in Average Recommendation 0.00
Number of Analysts Reporting 11
Strong Buy
1.0
Current: 1.41
Previous: 1.41
Change: 0.00
Strong Sell
5.0
Consensus Rating Industry Comparison
Industry: MED-BIOMED/GENE
Number of companies in industry with recommendations 380
Rank Recommendation relative to companies in its industry 268
Ranked 268 in Industry
1380 MED-BIOMED/GENE
Analyst Recommendations
Analysts recommending Strong Buy 8
Analysts recommending Moderate Buy 1
Analysts recommending Hold 2
Analysts recommending Moderate Sell 0
Analysts recommending Strong Sell 0
Vertical Bar Chart
Recommendations History
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 8 8 8 9
Moderate Buy 1 1 1 1
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
Mean Rec. 1.41 1.41 1.41 1.65

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.    RT = Real-Time,  EOD = End Of Day,  PD = Previous Day.   Market Data powered by QuoteMedia. Analyst ratings by Zacks.   Terms of Use.